Assaf C. Bester

2.2k total citations · 1 hit paper
16 papers, 1.3k citations indexed

About

Assaf C. Bester is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Assaf C. Bester has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Assaf C. Bester's work include DNA Repair Mechanisms (7 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (6 papers). Assaf C. Bester is often cited by papers focused on DNA Repair Mechanisms (7 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (6 papers). Assaf C. Bester collaborates with scholars based in Israel, United States and France. Assaf C. Bester's co-authors include Batsheva Kerem, Aaron Bensimon, Michael M. Im, Yifat S. Oren, Donna S. Shewach, Gideon Zamir, Maayan Roniger, E. Ozeri-Galai, Ayelet Rahat and Pier Paolo Pandolfi and has published in prestigious journals such as Cell, Molecular Cell and PLoS ONE.

In The Last Decade

Assaf C. Bester

16 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development

2011 635 citations Assaf C. Bester, Maayan Roniger et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Assaf C. Bester Israel	13	1.2k	363	278	248	181	16	1.3k
Etsuko Shibata United States	19	1.2k 1.0×	281 0.8×	367 1.3×	177 0.7×	102 0.6×	24	1.3k
Sara Rodríguez‐Acebes Spain	18	989 0.8×	189 0.5×	302 1.1×	153 0.6×	186 1.0×	27	1.2k
Giuseppina Giglia‐Mari France	16	1.1k 1.0×	242 0.7×	261 0.9×	206 0.8×	73 0.4×	20	1.3k
Mitsuo Wakasugi Japan	17	1.5k 1.2×	297 0.8×	276 1.0×	158 0.6×	124 0.7×	31	1.6k
Yuka Machida United States	12	1.1k 0.9×	167 0.5×	296 1.1×	188 0.8×	243 1.3×	15	1.2k
Stéphane Koundrioukoff France	18	1.5k 1.3×	158 0.4×	388 1.4×	301 1.2×	315 1.7×	24	1.7k
Lan N. Truong United States	14	1.1k 1.0×	175 0.5×	371 1.3×	143 0.6×	141 0.8×	16	1.2k
Magda Budzowska Netherlands	11	1.7k 1.4×	401 1.1×	433 1.6×	176 0.7×	268 1.5×	12	1.8k
Xi Shen United States	18	915 0.8×	311 0.9×	231 0.8×	113 0.5×	94 0.5×	31	1.2k
Shirley M.-H. Sy Hong Kong	20	1.5k 1.3×	298 0.8×	621 2.2×	520 2.1×	145 0.8×	26	1.8k

Countries citing papers authored by Assaf C. Bester

Since Specialization

Citations

This map shows the geographic impact of Assaf C. Bester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assaf C. Bester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assaf C. Bester more than expected).

Fields of papers citing papers by Assaf C. Bester

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Assaf C. Bester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assaf C. Bester. The network helps show where Assaf C. Bester may publish in the future.

Co-authorship network of co-authors of Assaf C. Bester

This figure shows the co-authorship network connecting the top 25 collaborators of Assaf C. Bester. A scholar is included among the top collaborators of Assaf C. Bester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Assaf C. Bester. Assaf C. Bester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Evangelista, John Erol, et al.. (2025). lncRNAlyzr: Enrichment Analysis for lncRNA Sets. Journal of Molecular Biology. 437(15). 168938–168938. 2 indexed citations

Amador, Raziel, Tamar Lahav, Dvir Aran, et al.. (2024). Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6’s role in hematopoietic differentiation and leukemia. Journal of Biomedical Science. 31(1). 27–27. 4 indexed citations

Bester, Assaf C., et al.. (2021). CRISPR-Based Approaches for the High-Throughput Characterization of Long Non-Coding RNAs. Non-Coding RNA. 7(4). 79–79. 13 indexed citations

Lewandowski, Jordan P., Gabrijela Dumbović, Taeyoung Hwang, et al.. (2020). The Tug1 lncRNA locus is essential for male fertility. Genome biology. 21(1). 237–237. 72 indexed citations

Bester, Assaf C., Jonathan D. Lee, Alejandro Chavez, et al.. (2018). An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance. Cell. 173(3). 649–664.e20. 237 indexed citations

Zarringhalam, Kourosh, et al.. (2017). Identification of competing endogenous RNAs of the tumor suppressor gene PTEN: A probabilistic approach. Scientific Reports. 7(1). 7755–7755. 17 indexed citations

Lamm, Noa, Assaf C. Bester, Michael M. Im, et al.. (2015). Folate levels modulate oncogene‐induced replication stress and tumorigenicity. EMBO Molecular Medicine. 7(9). 1138–1152. 28 indexed citations

Ben‐David, Eyal, Assaf C. Bester, Sagiv Shifman, & Batsheva Kerem. (2014). Transcriptional Dynamics in Colorectal Carcinogenesis: New Insights into the Role of c-Myc and miR17 in Benign to Cancer Transformation. Cancer Research. 74(19). 5532–5540. 18 indexed citations

Oren, Yifat S., Steven M. Rowe, Eric J. Sorscher, et al.. (2014). The unfolded protein response affects readthrough of premature termination codons. EMBO Molecular Medicine. 6(5). 685–701. 31 indexed citations

10.

Ozeri-Galai, E., et al.. (2014). Interplay between genetic and epigenetic factors governs common fragile site instability in cancer. Cellular and Molecular Life Sciences. 71(23). 4495–4506. 24 indexed citations

11.

Bester, Assaf C., et al.. (2013). Infection with retroviral vectors leads to perturbed DNA replication increasing vector integrations into fragile sites. Scientific Reports. 3(1). 2189–2189. 7 indexed citations

12.

Ozeri-Galai, E., Assaf C. Bester, & Batsheva Kerem. (2012). The complex basis underlying common fragile site instability in cancer. Trends in Genetics. 28(6). 295–302. 68 indexed citations

13.

Bester, Assaf C., Maayan Roniger, Yifat S. Oren, et al.. (2011). Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development. Cell. 145(3). 435–446. 635 indexed citations breakdown →

14.

Ozeri-Galai, E., Ronald Lebofsky, Ayelet Rahat, et al.. (2011). Failure of Origin Activation in Response to Fork Stalling Leads to Chromosomal Instability at Fragile Sites. Molecular Cell. 43(1). 122–131. 137 indexed citations

15.

Schwartz, Michal, Yifat S. Oren, Assaf C. Bester, et al.. (2009). Impaired Replication Stress Response in Cells from Immunodeficiency Patients Carrying Cernunnos/XLF Mutations. PLoS ONE. 4(2). e4516–e4516. 16 indexed citations

16.

Bester, Assaf C., Michal Schwartz, Manfred Schmidt, et al.. (2006). Fragile sites are preferential targets for integrations of MLV vectors in gene therapy. Gene Therapy. 13(13). 1057–1059. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact